13F COMBINATION REPORT
Brummer Multi-Strategy AB
Quarter ended Q4 2025 · Filed February 4, 2026 · Accession 0002003159-26-000002
Total Value
$16.5M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWMARK GROUP INC | NMRK | 200,493 | $3.5M | 21.01% |
| 2 | THE CIGNA GROUP | 125523100 | 11,818 | $3.3M | 19.66% |
| 3 | ARVINAS INC | ARVN | 166,342 | $2.0M | 11.93% |
| 4 | ABIVAX SA | AAVXF | 14,375 | $1.9M | 11.72% |
| 5 | IQVIA HLDGS INC | IQV | 8,183 | $1.8M | 11.15% |
| 6 | MARAVAI LIFESCIENCES HLDGS I | MARA | 457,707 | $1.5M | 8.99% |
| 7 | BECTON DICKINSON & CO | BDX | 5,176 | $1.0M | 6.07% |
| 8 | ATAI BECKLEY NV | N0731H103 | 234,915 | $960,802 | 5.81% |
| 9 | SOLENO THERAPEUTICS INC | SLNO | 8,741 | $404,708 | 2.45% |
| 10 | KLOTHO NEUROSCIENCES INC | 49876K103 | 606,757 | $175,353 | 1.06% |
| 11 | FOGHORN THERAPEUTICS INC | FHTX | 4,708 | $25,423 | 0.15% |